Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents
Clinical trial NCT00950612 · COMPLETED
Trial details
- NCT number
- NCT00950612
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-08
- Primary completion
- 2010-09-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.